Azenta, Inc. (FRA:BA3)

Market Cap	1.41B
Revenue (ttm)	506.11M
Net Income (ttm)	-50.71M
Shares Out	n/a
EPS (ttm)	-1.11
PE Ratio	n/a
Forward PE	44.79
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	12
Open	31.00
Previous Close	31.20
Day's Range	30.40 - 31.00
52-Week Range	21.80 - 52.50
Beta	n/a
RSI	61.91
Earnings Date	Nov 21, 2025

About Azenta

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments,...

• Industry: Commercial Physical and Biological Research
• Founded: 1978
• Employees: 3,300
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BA3

Financial Performance

In 2025, Azenta's revenue was $593.82 million, a decrease of -9.52% compared to the previous year's $656.32 million. Losses were -$59.50 million, -63.76% less than in 2024.

Financial numbers in USD